Company Description

Telo Genomics is a molecular diagnostics company that has developed a telomere-based platform with applications in multiple cancers and Alzheimer's disease. The TeloView® platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability - these data are used to identify specific disease mechanisms, predict disease risks, and determine effective treatments.